Skip to main content
Top
Published in: Cancer Causes & Control 4/2016

Open Access 01-04-2016 | Original paper

Childhood height, adult height, and the risk of prostate cancer

Authors: Lise Geisler Bjerregaard, Julie Aarestrup, Michael Gamborg, Theis Lange, Anne Tjønneland, Jennifer L. Baker

Published in: Cancer Causes & Control | Issue 4/2016

Login to get access

Abstract

Purpose

We previously showed that childhood height is positively associated with prostate cancer risk. It is, however, unknown whether childhood height exerts its effects independently of or through adult height. We investigated whether and to what extent childhood height has a direct effect on the risk of prostate cancer apart from adult height.

Methods

We included 5,871 men with height measured at ages 7 and 13 years in the Copenhagen School Health Records Register who also had adult (50–65 years) height measured in the Danish Diet, Cancer and Health study. Prostate cancer status was obtained through linkage to the Danish Cancer Registry. Direct and total effects of childhood height on prostate cancer risk were estimated from Cox regressions.

Results

From 1996 to 2012, 429 prostate cancers occurred. Child and adult heights were positively and significantly associated with prostate cancer risk. When adjusted for adult height, height at age 7 years was no longer significantly associated with the risk of prostate cancer. Height at 13 years was significantly and positively associated with prostate cancer risk even when adult height was adjusted for; per height z-score the hazard ratio was 1.15 [95 % confidence interval (CI) 1.01–1.32].

Conclusions

The effect of height at 13 years on the risk of prostate cancer was not entirely mediated through adult height, suggesting that child height and adult height may be associated with prostate cancer through different pathways.
Literature
1.
go back to reference Steward B, Wild C (2014) World cancer report 2014. International Agency for Research on Cancer, Lyon Steward B, Wild C (2014) World cancer report 2014. International Agency for Research on Cancer, Lyon
2.
go back to reference Møller H, Roswall N, Van Hemelrijck M, Larsen SB, Cuzick J, Holmberg L et al (2015) Prostate cancer incidence, clinical stage and survival in relation to obesity: a prospective cohort study in Denmark. Int J Cancer 136:1940–1947CrossRefPubMed Møller H, Roswall N, Van Hemelrijck M, Larsen SB, Cuzick J, Holmberg L et al (2015) Prostate cancer incidence, clinical stage and survival in relation to obesity: a prospective cohort study in Denmark. Int J Cancer 136:1940–1947CrossRefPubMed
3.
go back to reference MacInnis RJ, English DR (2006) Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 17:989–1003CrossRefPubMed MacInnis RJ, English DR (2006) Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 17:989–1003CrossRefPubMed
4.
go back to reference Zuccolo L, Harris R, Gunnell D, Oliver S, Lane JA, Davis M et al (2008) Height and prostate cancer risk: a large nested case–control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev 17:2325–2336CrossRefPubMedPubMedCentral Zuccolo L, Harris R, Gunnell D, Oliver S, Lane JA, Davis M et al (2008) Height and prostate cancer risk: a large nested case–control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev 17:2325–2336CrossRefPubMedPubMedCentral
5.
go back to reference Cook MB, Gamborg M, Aarestrup J, Sørensen TIA, Baker JL (2013) Childhood height and birth weight in relation to future prostate cancer risk: a cohort study based on the Copenhagen School Health Records Register. Cancer Epidemiol Biomark Prev 22:2232–2240CrossRef Cook MB, Gamborg M, Aarestrup J, Sørensen TIA, Baker JL (2013) Childhood height and birth weight in relation to future prostate cancer risk: a cohort study based on the Copenhagen School Health Records Register. Cancer Epidemiol Biomark Prev 22:2232–2240CrossRef
6.
go back to reference Baker JL, Olsen LW, Andersen I, Pearson S, Hansen B, Sørensen TIA (2009) Cohort profile: the Copenhagen School Health Records Register. Int J Epidemiol 38:656–662CrossRefPubMedPubMedCentral Baker JL, Olsen LW, Andersen I, Pearson S, Hansen B, Sørensen TIA (2009) Cohort profile: the Copenhagen School Health Records Register. Int J Epidemiol 38:656–662CrossRefPubMedPubMedCentral
8.
go back to reference Tjønneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G et al (2007) Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35:432–441CrossRefPubMed Tjønneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G et al (2007) Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35:432–441CrossRefPubMed
10.
go back to reference Cole TJ, Green PJ (1992) Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11:1305–1319CrossRefPubMed Cole TJ, Green PJ (1992) Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11:1305–1319CrossRefPubMed
11.
go back to reference Baron RM, Kenny DA (1986) The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173–1182CrossRefPubMed Baron RM, Kenny DA (1986) The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173–1182CrossRefPubMed
12.
go back to reference Lange T, Hansen JV (2011) Direct and indirect effects in a survival context. Epidemiology. 22:575–581CrossRefPubMed Lange T, Hansen JV (2011) Direct and indirect effects in a survival context. Epidemiology. 22:575–581CrossRefPubMed
13.
go back to reference Greenland S (1995) Dose–response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 6:356–365CrossRefPubMed Greenland S (1995) Dose–response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 6:356–365CrossRefPubMed
14.
15.
go back to reference Okasha M, Gunnell D, Holly J, Davey Smith G (2002) Childhood growth and adult cancer. Best Pract Res Clin Endocrinol Metab 16:225–241CrossRefPubMed Okasha M, Gunnell D, Holly J, Davey Smith G (2002) Childhood growth and adult cancer. Best Pract Res Clin Endocrinol Metab 16:225–241CrossRefPubMed
16.
go back to reference Power C, Lake JK, Cole TJ (1997) Body mass index and height from childhood to adulthood in the 1958 British born cohort. Am J Clin Nutr 66:1094–1101PubMed Power C, Lake JK, Cole TJ (1997) Body mass index and height from childhood to adulthood in the 1958 British born cohort. Am J Clin Nutr 66:1094–1101PubMed
17.
go back to reference Whitley E, Martin RM, Smith GD, Holly JM, Gunnell D (2009) Childhood stature and adult cancer risk: the Boyd Orr cohort. Cancer Causes Control 20:243–251CrossRefPubMed Whitley E, Martin RM, Smith GD, Holly JM, Gunnell D (2009) Childhood stature and adult cancer risk: the Boyd Orr cohort. Cancer Causes Control 20:243–251CrossRefPubMed
18.
go back to reference Aarestrup J, Gamborg M, Cook MB, Sørensen TIA, Baker JL (2014) Childhood body mass index and the risk of prostate cancer in adult men. Br J Cancer 111:207–212CrossRefPubMedPubMedCentral Aarestrup J, Gamborg M, Cook MB, Sørensen TIA, Baker JL (2014) Childhood body mass index and the risk of prostate cancer in adult men. Br J Cancer 111:207–212CrossRefPubMedPubMedCentral
19.
go back to reference Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1997) Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomark Prev 6:557–563 Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1997) Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomark Prev 6:557–563
20.
go back to reference Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA (2000) Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 151:541–549CrossRefPubMed Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA (2000) Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 151:541–549CrossRefPubMed
21.
go back to reference Pischon T, Boeing H, Weikert S, Allen N, Key T, Johnsen NF et al (2008) Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomark Prev 17:3252–3261CrossRef Pischon T, Boeing H, Weikert S, Allen N, Key T, Johnsen NF et al (2008) Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomark Prev 17:3252–3261CrossRef
22.
go back to reference Wallstrom P, Bjartell A, Gullberg B, Olsson H, Wirfalt E (2009) A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk. Br J Cancer 100:1799–1805CrossRefPubMedPubMedCentral Wallstrom P, Bjartell A, Gullberg B, Olsson H, Wirfalt E (2009) A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk. Br J Cancer 100:1799–1805CrossRefPubMedPubMedCentral
23.
go back to reference Hernandez BY, Park SY, Wilkens LR, Henderson BE, Kolonel LN (2009) Relationship of body mass, height, and weight gain to prostate cancer risk in the multiethnic cohort. Cancer Epidemiol Biomark Prev 18:2413–2421CrossRef Hernandez BY, Park SY, Wilkens LR, Henderson BE, Kolonel LN (2009) Relationship of body mass, height, and weight gain to prostate cancer risk in the multiethnic cohort. Cancer Epidemiol Biomark Prev 18:2413–2421CrossRef
24.
go back to reference Stocks T, Hergens MP, Englund A, Ye W, Stattin P (2010) Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort. Int J Cancer 127:1660–1668CrossRefPubMed Stocks T, Hergens MP, Englund A, Ye W, Stattin P (2010) Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort. Int J Cancer 127:1660–1668CrossRefPubMed
25.
go back to reference Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Parretta E et al (2013) Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis. J Endocrinol Invest 36:132–139CrossRefPubMed Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Parretta E et al (2013) Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis. J Endocrinol Invest 36:132–139CrossRefPubMed
26.
go back to reference Emerging Risk Factors C (2012) Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 41:1419–1433CrossRef Emerging Risk Factors C (2012) Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 41:1419–1433CrossRef
27.
go back to reference World Cancer Research Fund International/American Institute for Cancer Research (2014) Continuous update project report: diet, nutrition, physical activity, and prostate cancer World Cancer Research Fund International/American Institute for Cancer Research (2014) Continuous update project report: diet, nutrition, physical activity, and prostate cancer
28.
go back to reference Aarestrup J, Gamborg M, Cook MB, Baker JL (2015) Childhood height increases the risk of prostate cancer mortality. Eur J Cancer 51:1340–1345CrossRefPubMed Aarestrup J, Gamborg M, Cook MB, Baker JL (2015) Childhood height increases the risk of prostate cancer mortality. Eur J Cancer 51:1340–1345CrossRefPubMed
Metadata
Title
Childhood height, adult height, and the risk of prostate cancer
Authors
Lise Geisler Bjerregaard
Julie Aarestrup
Michael Gamborg
Theis Lange
Anne Tjønneland
Jennifer L. Baker
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 4/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0731-8

Other articles of this Issue 4/2016

Cancer Causes & Control 4/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine